BioHarvest Sciences Inc. surged 14.83% intraday after announcing its participation in the Craig-Hallum 16th Annual Alpha Select Conference on November 18, 2025, where CEO Ilan Sobel will host one-on-one investor meetings. The news highlighted strong momentum in the company’s consumer and CDMO divisions, including robust performance in its VINIA® capsule business, new product launches, and breakthroughs in plant-based exosome production. Additionally, the recent $19.9 million equity offering led by Craig-Hallum and the target of near-term adjusted EBITDA breakeven signaled financial strength and strategic progress, bolstering investor confidence. The conference participation and business updates reinforced BioHarvest’s positioning for sustainable growth, directly aligning with the stock’s sharp intraday rally.
Comments
No comments yet